Licensing activities are excellent opportunities for companies that want to expand their portfolio or gain return on investment in a relatively short period.
Out-licensing is a new phenomenon for the Indian pharma. The licensing strategy can make a critical drug globally accessible, and technology collaboration can enable an experimental drug for early entry. We also do product development and offer early entry to the Emerging & Expansion markets.
We cater to diverse portfolios across USA, EU, Japan & ANZ.
- Local expertise in most regulated and emerging markets.
- Insights into the needs of our customer and access to decision makers.
- Ability to handle the particularities with local know-how.
- Track record of successful license deals.
- Customized services - Regulatory Affairs, Intellectual Property, Quality & Supply Chain Management.